transcriptomics
Mayo Clinic, Personalis Ink Comprehensive Genomics Research Collaboration
Investigators intend to offer Personalis' comprehensive genomics testing to consenting patients for both clinical use and to aggregate data for ongoing research.
BostonGene Helping MassGeneral Improve Understanding of Follicular Lymphoma Progression, Treatment
The company will analyze tumor genetics and microenvironments to advance research into why some follicular lymphomas become aggressive and treatment response.
Recent studies in NSCLC, melanoma, and breast cancer suggest that major histocompatibility complex expression could guide checkpoint inhibitor selection.
Sema4, Avera Health Collaborate on Precision Oncology Program
The partnership, which will start with oncology, will introduce Sema4's genomic testing and Centrellis health intelligence technology to Avera's clinical and research programs.
Breast Cancer Immunotherapy Response Markers Emerge From Single-Cell Sequencing Study
Researchers identified several pre-treatment markers that correlated with T-cell expansion and could be predictive of response to a PD1 inhibitor.